Uniqema

Uniqema was a prominent global specialty chemicals company that operated as a division of Imperial Chemical Industries (ICI) before its acquisition. The company was a key supplier to the pharmaceutical and healthcare sectors, providing essential excipients, surfactants, and lipid-based delivery systems used in drug formulation and vaccine production. Their expertise in oleochemicals and surfactants made them a critical partner for many life science companies. In 2006, Croda International acquired Uniqema for approximately $760 million, integrating its operations to become a leader in the global specialty ingredients market. Today, Uniqema's legacy products and technologies continue to be marketed under the Croda Health Care brand.